Gemmothérapie Gros intestin / Dachang complément alimentaire
Food supplement declared in France, declaration No 2020-6-24, decision dated 1 June 2020
Gemmothérapie Gros intestin / Dachang complément alimentaire (MERYSTEME) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Vaccinium vitis-idaea 287 mg per day, Rubus idaeus 287 mg per day, Juglans regia 287 mg per day, Sambucus nigra 287 mg per day, Vitis vinifera 287 mg per day. 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- MERYSTEME
- Food business operator placing the product on the market
- MERYSTEME
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Bottle
- Daily dose
- 30 gouttes
- Directions for use
- 5 à 15 gouttes 2 fois par jour pendant 21 jours
- Not recommended (according to the manufacturer)
- Breastfeeding women, Pregnant women
Declaration 316349, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Vaccinium vitis-idaea L. | Jeune pousse | Autre extrait fluide | 287 mg |
| Rubus idaeus L. | Jeune pousse | Autre extrait fluide | 287 mg |
| Juglans regia L. | Bourgeon | Autre extrait fluide | 287 mg |
| Sambucus nigra L. | Jeune pousse | Autre extrait fluide | 287 mg |
| Vitis vinifera L. | Feuille (bourgeon) | Autre extrait fluide | 287 mg |
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
Déconseillé aux femmes enceintes et allaitantes. Tenir hors de portée des enfants
Regulatory points
- Conditions légales
Vaccinium vitis-idaea L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Sambucus nigra L.
Read the warning, when it applies and the studies cited
ELDER – SAMBUCUS
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Condition of application: Diaphoretic; Symptoms of colds, flus; Sinusitis, hay-fever; Joint pain.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Known adverse reactions
Condition of application: All products.
Stop use if hypersensitivity/allergy occur (Forster-Waldl et al. 2003).
Sources cited by Health Canada (1)
- Förster-Waldl E, Marchetii M, Schöll I, Focke M, Radauer C, Kinaciyan T, Nentwich I, Jäger S, Schmid ER, Boltz-Nitulescu G, Scheiner O, Jensen-Jarolim E. Type I allergy to elderberry (Sambucus nigra) is elicited by a 33.2 kDa allergen with significant homology to ribosomal inactivating proteins. Clinical and Experimental Allergy 2003;33(2):1703-1710. PubMed
Condition of application: All products except those making a diuretic claim.
When using this product diuretic effect may occur (Bradley 1992; Winston and Kuhn 2008; Barnes et al. 2007; Hoffman 2003).
Sources cited by Health Canada (2)
- Barnes J, Anderson LA, Philipson JD. Herbal Medicines. 3rd edition. London (GB): The Pharmaceutical Press; 2007.
- Winston D and Kuhn MA. Herbal Therapy & Supplements A Scientific and Traditional Approach. Philadelphia (PA): Lippincott Williams & Wilkins; 2008.
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : MERYSTEME
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Gemmothérapie Gros intestin / Dachang complément alimentaire (MERYSTEME): composition and regulation”, https://compoatlas.com/en/supplements/products/316349-gemmotherapie-gros-intestin-dachang-complement-alimentaire, updated 15 November 2026.